XTalks

APRIL 24, 2023

These are, in my view, the most valid comparisons, particularly in inherited diseases where the genotype is obviously the same in each individual patient, and as a consequence, the difference in phenotype after gene therapy is a true difference,” he adds.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

The Pharma Data

DECEMBER 9, 2020

The creation of Overland isn’t the only exciting thing happening for international life sciences companies and organizations. Amolyt has also acquired an option to license the identified candidates for future clinical development. Below is a roundup of some of this week’s interesting news. million in a second financing round.

In-Vivo 52

In-Vivo In-Vitro Antibody Development 52

XTalks

MARCH 26, 2025

South San Francisco-based biotech Kezar Life Sciences (NASDAQ: KZR) announced topline results from its Phase IIa PORTOLA trial evaluating zetomipzomib for the treatment of autoimmune hepatitis (AIH). Attendees will learn how clinical trial assays and genotyping kits can enhance research and clinical insight. million and $94.2

Trials 66

Trials Life Science Clinical Trials Clinical Trials 66